Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
News
Nature Biotechnology 25, 150–151 (1 February 2007) | doi:10.1038/nbt0207-150
Democrats prioritize pricing, generics and drug safety
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
